Hao Xie

TL;DR: The preclinical findings regarding the pathophysiology of late radiation-induced vascular damage are reviewed, and the clinical incidence and risk factors for each type of vasculopathy are discussed.

TL;DR: Male breast cancer (MBC) is a rare disease for which there is limited understanding of treatment patterns and prognostic factors and there is a need to understand more about how these patterns are changed over time.

TL;DR: In this article, the authors used the National Cancer Database (NCD) to identify patients who underwent surgery and chemotherapy for stage I-III cholangiocarcinoma between 2006 and 2014.

TL;DR: Pre-clinical evidence supporting the suitability of targeting this signaling pathway in cancers is summarized, and published and ongoing clinical trial data on single agent or combination therapeutic strategies, targeting Hedgehog/GLI signaling pathway, in both advanced solid tumors and hematologic malignancies are provided.

TL;DR: Bevacizumab treatment results in excellent clinical and radiologic response in patients with RN caused by common forms of radiation therapy, and the safety profile of bevacIZumab use in RN is acceptable.